Are AGMB insiders buying or selling?

Over the last 90 days, AGMB insiders were net buyers, reporting $399,970 of open-market purchases and $0.00 of sales.

When was the last AGMB insider purchase?

The most recent open-market purchase of AgomAb Therapeutics NV stock by an insider was reported on Oct 21, 2026, one of 5 purchases in the last 90 days.

Where does AGMB insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that AgomAb Therapeutics NV officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

AGMBSector not reported

AgomAb Therapeutics NV (AGMB) Insider Trading

In the last 90 days, 3 AgomAb Therapeutics NV (AGMB) insiders reported 5 open-market purchases totaling $399,970 and no sales. The most recent open-market purchase was reported on Oct 21, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 2
90-day purchase value: $399,970
Corporate buyers: 3
Latest transaction: Oct 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Oct 21, 2026	David R Epstein	Corporate insider	Open Market Purchase	10,000	$8.88	$88,800
Oct 8, 2026	David R Epstein	Corporate insider	Open Market Purchase	5,000	$8.90	$44,500
Oct 6, 2026	Tim Jasper Knotnerus	Chief Executive Officer	Open Market Purchase	11,000	$8.58	$94,380
Oct 6, 2026	Pierre Thadee Victor Kemula	Chief Financial Officer	Open Market Purchase	10,000	$8.59	$85,940
Oct 6, 2026	David R Epstein	Corporate insider	Open Market Purchase	10,000	$8.64	$86,350

Common questions

AGMB insider trading FAQ

Are AGMB insiders buying or selling?: Over the last 90 days, AGMB insiders were net buyers, reporting $399,970 of open-market purchases and $0.00 of sales.
When was the last AGMB insider purchase?: The most recent open-market purchase of AgomAb Therapeutics NV stock by an insider was reported on Oct 21, 2026, one of 5 purchases in the last 90 days.
Where does AGMB insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that AgomAb Therapeutics NV officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.